LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 7 of total 7

Search options

  1. Article: Tracheal atypical solitary carcinoid in a so called "difficult asthma": a diagnostic challenge.

    Turrin, Martina / Pontoriero, Francesca Maria / Fiorentù, Giordano / Grisostomi, Giulia / Zampieri, Francesca / Savoia, Francesca / Catino, Cosimo / Zanardi, Giuseppe / Peditto, Piera / Malacchini, Nicola / Zeraj, Fabiola / Bonato, Matteo / Sacchi, Diana / Guido, Maria / Morana, Giovanni / Romagnoli, Micaela

    Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace

    2023  

    Abstract: This report describes the case of a 46-year-old non-smoker housewife. She presented to our attention having a diagnosis of "difficult asthma" from another center in the previous two years. She had no allergies and had not been exposed to an excessive ... ...

    Abstract This report describes the case of a 46-year-old non-smoker housewife. She presented to our attention having a diagnosis of "difficult asthma" from another center in the previous two years. She had no allergies and had not been exposed to an excessive amount of noxious stimuli. Her chronic respiratory symptoms (dyspnea on exertion with wheezing) remained uncontrolled despite maximal anti-asthmatic inhaled therapy. An HRCT scan was performed to further investigate other pulmonary diseases that mimic asthma. It revealed a pedunculated endotracheal lesion with regular borders that obstructed 90% of the tracheal lumen. The lesion was removed via rigid bronchoscopy with laser endobronchial; histological examination revealed the presence of atypical carcinoid. Atypical carcinoids are a rare subtype of neuroendocrine lung tumor that accounts for 2% of all thoracic malignancies. They frequently arise from the central airways and cause obstructive symptoms such as coughing, wheezing, chest pain, or recurrent obstructing pneumonia, which is caused by central airway obstruction. Clinical onset is gradual and characterized by non-specific symptoms, which frequently result in misdiagnosis. As a result, in a young patient with progressive dyspnea, chronic cough, and wheezing that is not responding to anti-asthmatic treatment, second-level investigations are required and may lead to a definite diagnosis, allowing the appropriate course of treatment to begin.
    Language English
    Publishing date 2023-08-02
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 1160940-0
    ISSN 1122-0643 ; 1120-0391
    ISSN 1122-0643 ; 1120-0391
    DOI 10.4081/monaldi.2023.2586
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Multidimensional 3-Month Follow-Up of Severe COVID-19: Airways beyond the Parenchyma in Symptomatic Patients.

    Bonato, Matteo / Peditto, Piera / Landini, Nicholas / Fraccaro, Alessia / Catino, Cosimo / Cuzzola, Maria / Malacchini, Nicola / Savoia, Francesca / Roma, Nicola / Salasnich, Mauro / Turrin, Martina / Zampieri, Francesca / Zanardi, Giuseppe / Zeraj, Fabiola / Rattazzi, Marcello / Peta, Mario / Baraldo, Simonetta / Saetta, Marina / Fusaro, Michele /
    Morana, Giovanni / Romagnoli, Micaela

    Journal of clinical medicine

    2022  Volume 11, Issue 14

    Abstract: SARS-CoV-2 may lead to a large spectrum of respiratory manifestations, including pulmonary sequelae. We conducted a single-center longitudinal study of survivors from severe COVID-19 cases who underwent a chest CT during hospitalization ( ... ...

    Abstract SARS-CoV-2 may lead to a large spectrum of respiratory manifestations, including pulmonary sequelae. We conducted a single-center longitudinal study of survivors from severe COVID-19 cases who underwent a chest CT during hospitalization (CT
    Language English
    Publishing date 2022-07-13
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm11144046
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Pneumothorax and/or Pneumomediastinum Worsens the Prognosis of COVID-19 Patients with Severe Acute Respiratory Failure: A Multicenter Retrospective Case-Control Study in the North-East of Italy.

    Bonato, Matteo / Fraccaro, Alessia / Landini, Nicholas / Zanardi, Giuseppe / Catino, Cosimo / Savoia, Francesca / Malacchini, Nicola / Zeraj, Fabiola / Peditto, Piera / Catalanotti, Vito / Marcon, Elisabetta / Rossi, Emanuela / Pauletti, Alessia / Galvan, Silvia / Adami, Riccardo / Tiepolo, Marta / Salasnich, Mauro / Cuzzola, Maria / Zampieri, Francesca /
    Rattazzi, Marcello / Peta, Mario / Baraldo, Simonetta / Saetta, Marina / Morana, Giovanni / Romagnoli, Micaela

    Journal of clinical medicine

    2021  Volume 10, Issue 21

    Abstract: Pneumothorax (PNX) and pneumomediastinum (PNM) are potential complications of COVID-19, but their influence on patients' outcomes remains unclear. The aim of the study was to assess incidence, risk factors, and outcomes of severe COVID-19 complicated ... ...

    Abstract Pneumothorax (PNX) and pneumomediastinum (PNM) are potential complications of COVID-19, but their influence on patients' outcomes remains unclear. The aim of the study was to assess incidence, risk factors, and outcomes of severe COVID-19 complicated with PNX/PNM.
    Methods: A retrospective multicenter case-control analysis was conducted in COVID-19 patients admitted for respiratory failure in intermediate care units of the Treviso area, Italy, from March 2020 to April 2021. Clinical characteristics and outcomes of patients with and without PNX/PNM were compared.
    Results: Among 1213 patients, PNX and/or PNM incidence was 4.5%. Among these, 42% had PNX and PNM, 33.5% only PNX, and 24.5% only PNM. COVID-19 patients with PNX/PNM showed higher in-hospital (
    Conclusion: PNX/PNM are complications of COVID-19 associated with a worse prognosis in terms of mortality and length of hospitalization. Although they are more frequent in ventilated patients, they can occur in non-ventilated, suggesting that mechanisms other than barotrauma might contribute to their presentation.
    Language English
    Publishing date 2021-10-21
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm10214835
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Competence in flexible bronchoscopy and basic biopsy technique.

    Valentini, Ilaria / Lazzari Agli, Luigi / Michieletto, Lucio / Innocenti, Margherita / Savoia, Francesca / Del Prato, Bruno / Mancino, Laura / Maddau, Cristina / Romano, Annamaria / Puorto, Antonella / Corbetta, Lorenzo / Fois, Alessandro

    Panminerva medica

    2018  Volume 61, Issue 3, Page(s) 232–248

    Abstract: Diagnostic bronchoscopy and tissue sampling techniques using forceps (endobronchial biopsy [EBB] and transbronchial biopsies [TBB]) or needle aspiration (transbronchial needle aspiration-TBNA), all performed with a flexible bronchoscope, are the basic ... ...

    Abstract Diagnostic bronchoscopy and tissue sampling techniques using forceps (endobronchial biopsy [EBB] and transbronchial biopsies [TBB]) or needle aspiration (transbronchial needle aspiration-TBNA), all performed with a flexible bronchoscope, are the basic elements of any interventional procedure. The flexible fibrobronchoscopy allows the visualization of the airways and is used both for diagnostic and therapeutic purposes. The working channel of both fibrobronchoscopes with optical fibers and videobronchoscopes, even if of relatively small diameter, allows the insertion of various diagnostic and therapeutic accessories. Fiber optic systems have been widely replaced by video cameras using a miniaturized charge-coupled device camera positioned at the end of the scope that provides electronic transmission of images to a monitor. The indications for both diagnostic and therapeutic fibrobronchoscopy derive from a correct evaluation of symptoms and objective signs of the patient and from the correct interpretation of imaging methods. Although bronchoscopy techniques keep evolving at a rapid pace, basic procedures such as bronchoalveolar lavage, transbronchial lung biopsy, and transbronchial needle aspiration still play a key role in pulmonary disease diagnostics, and therefore, these methods must still be part of the training of interventional pulmonologists. Trainees will acquire a thorough knowledge of thoracic anatomy and become skilled in the interpretation of thoracic imaging, after which they will be given a theoretical and practical training course on virtual reality simulators, on animal or cadaver models, the effectiveness of which has been fully demonstrated by scientific studies. Specific DOPS tests have been developed for a qualitative evaluation of procedures on simulators, on animal models and on the patient.
    MeSH term(s) Anticoagulants/therapeutic use ; Biopsy, Needle ; Bronchoscopy/education ; Clinical Competence ; Computer Simulation ; Endoscopy ; Equipment Design ; Humans ; Lung/pathology ; Lung Diseases/diagnosis ; Lung Diseases, Interstitial/diagnosis ; Lung Neoplasms/diagnosis ; Optical Fibers ; Platelet Aggregation Inhibitors/therapeutic use ; Pulmonary Medicine/education ; Purinergic P2Y Receptor Antagonists/therapeutic use ; Video Recording ; Warfarin/therapeutic use
    Chemical Substances Anticoagulants ; Platelet Aggregation Inhibitors ; Purinergic P2Y Receptor Antagonists ; Warfarin (5Q7ZVV76EI)
    Language English
    Publishing date 2018-10-31
    Publishing country Italy
    Document type Journal Article ; Review
    ZDB-ID 123572-2
    ISSN 1827-1898 ; 0031-0808
    ISSN (online) 1827-1898
    ISSN 0031-0808
    DOI 10.23736/S0031-0808.18.03563-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: "Hospital at home" for neuromuscular disease patients with respiratory tract infection: a pilot study.

    Vianello, Andrea / Savoia, Francesca / Pipitone, Emanuela / Nordio, Beatrice / Gallina, Giulia / Paladini, Luciana / Concas, Alessandra / Arcaro, Giovanna / Gallan, Federico / Pegoraro, Elena

    Respiratory care

    2013  Volume 58, Issue 12, Page(s) 2061–2068

    Abstract: Background: The "hospital-at-home" model may provide adequate care without an adverse effect on clinical outcome, and is generally well received by users. Our objective was to compare hospital-at-home and in-patient hospital care for neuromuscular ... ...

    Abstract Background: The "hospital-at-home" model may provide adequate care without an adverse effect on clinical outcome, and is generally well received by users. Our objective was to compare hospital-at-home and in-patient hospital care for neuromuscular disease (NMD) patients with respiratory tract infections.
    Methods: We conducted a prospective randomized controlled trial in a university teaching hospital offering secondary care service to a population of approximately 500,000. We recruited selected NMD patients with respiratory tract infection for whom hospital admission had been recommended after medical assessment. Hospital-at-home was provided as an alternative to in-patient admission. The main outcome measures were need for hospitalization, treatment failure, time to recovery, death during the first 3 months following exacerbation, and cost of patient care.
    Results: Among 59 consecutive NMD patients eligible for the study, 53 met the criteria for hospital-at-home. Twenty-six subjects were randomized to home care and 27 to hospital care. No significant differences were found in treatment failure (8/26 vs 13/27, P = .19), time to recovery (8.9 ± 4.6 vs 9 ± 8.9 d, P = .21), or mortality at 3 months (3/26 vs 4/27 deaths, P = .42) between the groups. Hospital-at-home failure was independently correlated with type of NMD (P = .004) with an odds ratio of failure of 17.3 (95% CI 2.1 to infinity) for subjects with amyotrophic lateral sclerosis. The total and daily direct cost of patient healthcare was significantly lower for the subjects who were successfully treated at home, compared to the hospitalized individuals.
    Conclusions: Hospital-at-home is an effective alternative to hospital admission for selected NMD patients with respiratory tract infections.
    MeSH term(s) Adult ; Aged ; Costs and Cost Analysis ; Female ; Home Care Services, Hospital-Based/economics ; Home Care Services, Hospital-Based/statistics & numerical data ; Hospitalization/economics ; Hospitalization/statistics & numerical data ; Hospitals, University/statistics & numerical data ; Humans ; Italy ; Male ; Middle Aged ; Neuromuscular Diseases/complications ; Neuromuscular Diseases/therapy ; Outcome and Process Assessment (Health Care) ; Patient Selection ; Pilot Projects ; Respiratory Tract Infections/etiology ; Respiratory Tract Infections/therapy ; Survival Analysis ; Treatment Failure ; Treatment Outcome
    Language English
    Publishing date 2013-12
    Publishing country United States
    Document type Comparative Study ; Journal Article ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
    ZDB-ID 603252-7
    ISSN 1943-3654 ; 0098-9142 ; 0020-1324
    ISSN (online) 1943-3654
    ISSN 0098-9142 ; 0020-1324
    DOI 10.4187/respcare.02501
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Omalizumab management beyond clinical trials: the added value of a network model.

    Caminati, Marco / Senna, Gianenrico / Chieco Bianchi, Fulvia / Marchi, Maria Rita / Vianello, Andrea / Micheletto, Claudio / Pomari, Carlo / Tognella, Silvia / Savoia, Francesca / Mirisola, Valentina / Rossi, Andrea

    Pulmonary pharmacology & therapeutics

    2014  Volume 29, Issue 1, Page(s) 74–79

    Abstract: Background: Omalizumab is effective and safe in severe allergic asthma. Few data are available about its impact on lung function and on asthma comorbidities, long-term follow-up of treated patients, adherence, non-responders profile, and optimal ... ...

    Abstract Background: Omalizumab is effective and safe in severe allergic asthma. Few data are available about its impact on lung function and on asthma comorbidities, long-term follow-up of treated patients, adherence, non-responders profile, and optimal treatment duration.
    Objective: We aimed at evaluating omalizumab-related clinical outcomes and unmet needs in a real-life setting.
    Methods: We created a collaborative network (NEONet - North East Omalizumab Network) involving 9 Allergy and Respiratory referral centres for severe asthma placed in the North-East of Italy. Patients' data were entered into a common study database shared by all the participating physicians. A preliminary retrospective analysis was performed.
    Results: Patients come from a common well-defined geographical and environmental district providing a homogeneous population sample. A moderate but statistically significant improvement of the FEV1, and an increasing proportion of exacerbations-free patients were observed since the treatment start. These findings were independent of the baseline severity of bronchial obstruction. A positive impact of omalizumab on rhinitis in patients with both asthma and rhinitis was detected. Moreover the efficacy of omalizumab on asthma seemed not to be affected by the baseline severity of rhinitis.
    Conclusion: Our retrospective analysis represents a preliminary report from the NEONet activity. It confirmed omalizumab efficacy and provided some new insights about its impact on lung function and on comorbid rhinitis. The network approach, under a prospective view, allows creating a large uniform database, by means of a standardized shared tool for data collecting, and joining a multidisciplinary expertise.
    MeSH term(s) Adult ; Anti-Asthmatic Agents/adverse effects ; Anti-Asthmatic Agents/therapeutic use ; Asthma/drug therapy ; Asthma/physiopathology ; Cooperative Behavior ; Data Collection/methods ; Databases, Factual ; Female ; Forced Expiratory Volume ; Health Services Needs and Demand ; Humans ; Italy ; Male ; Middle Aged ; Models, Organizational ; Omalizumab/adverse effects ; Omalizumab/therapeutic use ; Retrospective Studies ; Rhinitis, Allergic/drug therapy ; Severity of Illness Index
    Chemical Substances Anti-Asthmatic Agents ; Omalizumab (2P471X1Z11)
    Language English
    Publishing date 2014-10
    Publishing country England
    Document type Journal Article ; Multicenter Study
    ZDB-ID 1399707-5
    ISSN 1522-9629 ; 1094-5539
    ISSN (online) 1522-9629
    ISSN 1094-5539
    DOI 10.1016/j.pupt.2014.01.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Mild/Moderate Asthma Network in Italy (MANI): a long-term observational study.

    Braido, Fulvio / Blasi, Francesco / Canonica, Giorgio Walter / Paggiaro, Pierluigi / Beghè, Bianca / Bonini, Matteo / Carpagnano, Giovanna Elisiana / Del Giacco, Stefano / Lavorini, Federico / Milanese, Manlio / Patella, Vincenzo / Santus, Pierachille / Contoli, Marco / Allegrini, Chiara / Baiardini, Ilaria / Bonzano, Laura / Caiaffa, Maria Filomena / Castelnuovo, Paolo / Corsico, Angelo Guido /
    Cosmi, Lorenzo / Costantino, Maria Teresa / Cottini, Marcello / Crimi, Nunzio / Crivellaro, Maria Angiola / D'Alò, Simona / Folletti, Ilenia / Fornari, Dario / Foschino-Barbaro, Maria Pia / Franceschini, Laura / Gargano, Domenico / Oliani, Kim Lokar / Maniscalco, Mauro / Melissari, Laura / Montagni, Marcello / Montuschi, Paolo / Murgia, Nicola / Pannofino, Alessandro / Papi, Alberto / Parente, Roberta / Pelaia, Girolamo / Pini, Laura / Puggioni, Francesca / Pulerà, Nolita / Resta, Onofrio / Ricciardi, Luisa / Ridolo, Erminia / Savi, Eleonora / Savoia, Francesca / Scala, Guglielmo / Senna, Gianenrico / Tripodi, Salvatore / Vatrella, Alessandro / Ventura, Maria Teresa / Viviano, Vittorio Maria / Yacoub, Mona-Rita

    The Journal of asthma : official journal of the Association for the Care of Asthma

    2021  Volume 59, Issue 9, Page(s) 1908–1913

    Abstract: Objective: The prevalence of asthma in Italy is estimated to be around 4%; it affects approximately 2,000,000 citizens, and up to 80-90% of patients have mild-to-moderate asthma. Despite the clinical relevance of mild-to-moderate asthma, longitudinal ... ...

    Abstract Objective: The prevalence of asthma in Italy is estimated to be around 4%; it affects approximately 2,000,000 citizens, and up to 80-90% of patients have mild-to-moderate asthma. Despite the clinical relevance of mild-to-moderate asthma, longitudinal observational data are very limited, including data on disease progression (worsening vs. improvement), the response to treatment, and prognosis. Studies are needed to develop long-term, observational, real-life research in large cohorts. The primary outcomes of this study will be based on prospective observation and the epidemiological evolution of mild and moderate asthma. Secondary outcomes will include patient-reported outcomes, treatments over time, disease-related functional and inflammatory patterns, and environmental and life-style influences.
    Methods: This study, called the Mild/Moderate Asthma Network of Italy (MANI), is a research initiative launched by the Italian Respiratory Society and the Italian Society of Allergology, Asthma and Clinical Immunology. MANI is a cluster-based, real world, cross-sectional, prospective, observational cohort study that includes 20,000 patients with mild-to-moderate asthma. (ClinicalTrials.gov Identifier: NCT04796844).
    Results and conclusion: Despite advances in asthma care, several research gaps remain to be addressed through clinical research. This study will add important new knowledge about long-term disease history, the transferability of clinical research results to daily practice, the efficacy of currently recommended strategies, and their impact on the burden and evolution of the disease.
    Abbreviations: MANI:Mild/Moderate Asthma Network of ItalySANI:Severe Asthma Network ItalyGINA:Global Initiative for AsthmaSABA:short acting β2-agonistsICS:inhaled corticosteroidsCRF:Case Report Form.
    MeSH term(s) Administration, Inhalation ; Anti-Asthmatic Agents/therapeutic use ; Asthma/drug therapy ; Asthma/epidemiology ; Cross-Sectional Studies ; Disease Progression ; Humans ; Prospective Studies ; Quality of Life
    Chemical Substances Anti-Asthmatic Agents
    Language English
    Publishing date 2021-09-01
    Publishing country England
    Document type Journal Article ; Observational Study ; Research Support, Non-U.S. Gov't
    ZDB-ID 603816-5
    ISSN 1532-4303 ; 0277-0903
    ISSN (online) 1532-4303
    ISSN 0277-0903
    DOI 10.1080/02770903.2021.1968895
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top